A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight ...
The 44-year-old comedian is the skinniest she's looked in decades thanks to Mounjaro, which she began taking earlier this ...
Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone amylin that slows digestion and reduces hunger.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback